SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-056868
Filing Date
2015-06-26
Accepted
2015-06-26 17:14:46
Documents
1
Period of Report
2015-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4469
  Complete submission text file 0001209191-15-056868.txt   5900
Mailing Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241
Business Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Issuer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2656 CROSSPARK ROAD SUITE 100 CORALVILLE IA 52241
Business Address
Johnson Gordon K (Reporting) CIK: 0001638367 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 15956002